Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 20/20 | 0.62 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | DRD2 | P14416 | 1/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6885142 | 0.94 | CXCR4 (0.61) | CXCR4CHRM2CYP2D6DRD2OPRM1 | |
| SCHEMBL4066844 | 0.89 | CXCR4 (0.59) | CXCR4CHRM2CYP2D6DRD2OPRM1 | |
| SCHEMBL4064430 | 0.89 | CXCR4 (0.60) | CXCR4CHRM2CYP2D6DRD2OPRM1 | |
| SCHEMBL4063211 | 0.88 | CXCR4 (0.69) | CXCR4CHRM2CYP2D6DRD2OPRM1 | |
| SCHEMBL4066509 | 0.87 | CXCR4 (0.58) | CXCR4CHRM2CYP2D6DRD2OPRM1 | |
| SCHEMBL6890383 | 0.87 | CXCR4 (0.60) | CXCR4CHRM2CYP2D6DRD2OPRM1 | |
| SCHEMBL4069490 | 0.86 | CXCR4 (0.68) | CXCR4CHRM2CYP2D6DRD2OPRM1 | |
| SCHEMBL4065649 | 0.86 | CXCR4 (0.72) | CXCR4CHRM2CYP2D6DRD2OPRM1 | |
| SCHEMBL4062379 | 0.84 | CXCR4 (0.58) | CXCR4CHRM2CYP2D6DRD2OPRM1 | |
| SCHEMBL5055219 | 0.84 | CXCR4 (0.67) | CXCR4CHRM2CYP2D6DRD2OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6835731-B2 | Viricides; antiinflammatory agents; antiallergens; antiarthritic agents | ANORMED, INC. (CA) | 2004-12-28 | — | — | US | disclosed |